Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Pexidartinib often causes liver issues and fatigue, especially in women.

Caraway, Chinese chives, and cassia may improve health and prevent diseases due to their nutrients and medicinal properties.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Syphilis is becoming more common and remains a major health problem due to challenges in prevention and treatment.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Dengue is more severe in children than adults, with higher risks of serious complications and death.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

Biologics for severe asthma have known side effects, but some new risks need more study.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

New cytokine-targeted therapies show promise for treating alopecia areata.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Systemic retinoids do not increase COVID-19 risk or severity.

GERD symptoms are linked to acid exposure time and daytime sleepiness, influenced by ghrelin levels.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Many people with inflammatory bowel disease have a vitamin C deficiency, which can lead to scurvy symptoms.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.